<unk><unk>  may be classified into several subtypes based on the origin (primary and secondary) and molecular alterations (classic, proneural, mesenchymal, and neural).The heterogeneity of GBM profiles leads to different treatment efficacy among patients. The therapy must be personalized to target each patient’s alterations in the molecular level.
Glioblastoma multiforme classification
Glioma classification
Meningioma classification
Medulloblastoma classification
Myxoma classification
Ganglioglioma classification
Hamartoma classification
Paraganglioma classification